Clause 26.1

What this clause covers

Promotional material must be certified by a medical signatory (or approved person) before use, and a copy retained with a certificate. Failure to certify — or to certify correctly before first use — is one of the most administratively common breaches found in PMCPA cases.

PMCPA Cases — Clause 26.1

68 cases

📅 8 Mar 2026 · Grünenthal

Grünenthal: LinkedIn ‘like’ treated as promotion of Qutenza to public and HCPs (AUTH/3177/3/19)

Clause 14.1 Clause 26.1 Clause 26.2 Clause 28.1 +5 more

↗

📅 8 Mar 2026 · Merz Pharma UK

Merz: Representative’s Instagram post with Bocouture pack shot ruled advertising a POM to the public

Clause 15.2 Clause 26.1 Clause 9.1

↗

📅 8 Mar 2026 · Sanofi

Sanofi Twitter post about Epilim and the IMMDS safety review: public-facing content ruled misleading and an advert to the public (AUTH/3166/2/19)

Clause 14.5 Clause 26.1 Clause 26.2 Clause 9.1

↗

🔒

See all 68 cases for Clause 26.1

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

Already a member? Sign in

PMCPA Cases — Clause 26.1

Grünenthal: LinkedIn ‘like’ treated as promotion of Qutenza to public and HCPs (AUTH/3177/3/19)

Merz: Representative’s Instagram post with Bocouture pack shot ruled advertising a POM to the public

Sanofi Twitter post about Epilim and the IMMDS safety review: public-facing content ruled misleading and an advert to the public (AUTH/3166/2/19)

See all 68 cases for Clause 26.1

📰 Weekly PMCPA Case Breakdown